Multi-purpose evaluation of H2-antagonist usage.
At Cabrini Medical Center, drug usage evaluation (DUE) and monthly purchasing data analysis were used to determine the indications for which H2 antagonists were being used, the appropriateness of parenteral therapy, the use of extended dosing intervals, and the cost effectiveness of cimetidine (Tagamet). The study was also used to review a decision of the P & T Committee to maintain cimetidine and remove ranitidine from the hospital formulary.
Gianarkis
D
D
Cabrini Medical Center, New York 10003.
D002927:Cimetidine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004348:Drug Labeling / Q000592:standards; D004363:Drug Utilization / Q000706:statistics & numerical data*; D005572:Formularies, Hospital as Topic; D006801:Humans; D007263:Infusions, Parenteral / Q000592:standards; D009519:New York City; D010606:Pharmacy and Therapeutics Committee; D011899:Ranitidine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014600:Utilization Review
D002927:Cimetidine; D011899:Ranitidine